Service Monitoring. Customer gives express consent for Vodafone to monitor Customer’s use of the Service (and disclose and otherwise use the information obtained) only to: (a) the extent allowed by Applicable Law; (b) comply with Applicable Law; (c) protect the Network from misuse; (d) protect the integrity of the public internet and/or Vodafone’s systems and Networks; (e) the extent necessary to determine if Customer has breached any conditions or restrictions on use of the Service; (f) provide the Service; and/or (g) take other actions agreed or requested by Customer.
Service Monitoring. Company is under no obligation to monitor a customer’s usage, bandwidth, transmissions and/or content of service. However, Company may monitor the usage, bandwidth, transmissions and content of service periodically to (i) comply with any necessary laws, regulations or other governmental requests or (ii) operate service properly or to protect itself, its network and its customers and subscribers. Company reserves the right to modify, reject or eliminate any information residing on or transmitted to its server that it, in its sole discretion, believes is unacceptable or in violation of this AUP or any other terms and provisions applicable to service.
Service Monitoring. Microsoft security personnel verify logs at least every six months to propose remediation efforts if necessary.
Service Monitoring. The Service provided will be subject to lawful intercept and/or monitoring as may be required by the country’s regulatory and law enforcement agencies where the Service Location(s) is at pursuant to the Applicable Law, and TIME will have to ensure that such requirements are in full compliance according to the Applicable Law, and Customer hereby consents to such lawful intercept and/or monitoring activities.
Service Monitoring. 10.1 Performance monitoring will be in line with service standards and the pharmacy may be monitored on the following: Availability of appropriate material to support the provision of advice to the client group. Maintenance of accurate records as required by the PGD. Reviews of standard operating procedures and updates as necessary. Participation in the bi-annual review of service provision including any updated developments. The outcomes of any patient experience surveys, feedback or complaints. The proportion of the number of women under 25 who received EHC and have been given a Chlamydia screening pack. The proportion of Chlamydia screening packs that is returned to the screening service from women under 25. A review of the number of occasions when an accredited pharmacist was not available to provide the services at the pharmacy.
10.2 Information outlining the process of the service must be cascaded to other pharmacy staff.
10.3 Non-pharmacist staff must be trained to refer clients to an accredited pharmacist. Where an accredited pharmacist is unavailable on the premises, clients should be signposted to an appropriate alternative service.
10.4 Non-pharmacists may not be accredited nor are they allowed, by law, to supply via this patient group direction (PGD). Pharmacies should inform the CCC as soon as possible in situations where an accredited pharmacist will no longer be available to provide the service.
10.5 Pharmacies should inform the CCC as soon as possible in situations where the designated pharmacy signatory is no longer able to retain responsibility for the SLA operating in a given accredited pharmacy, to enable transfer of designated signatory status or termination of the agreement.
Service Monitoring. Customer acknowledges that the Supplier continuously monitors the Service to: (a) track usage, (b) provide support, (c) monitor the performance, integrity, and stability of the Service’s infrastructure, (d) provide usage statistics to its billing agent, (e) prevent or remediate technical issues, and (f) detect and address illegal acts or violations of Section 2.3 (Services Licence).
Service Monitoring. Acuity security personnel verify logs at least every six months to propose remediation efforts if necessary.
Service Monitoring. IBM security personnel verify logs at least every six months to propose remediation efforts if necessary.
Service Monitoring. Customer acknowledges that Sophos continuously monitors the Service to: (a) track usage and Entitlement, (b) provide support, (c) monitor the performance,
Service Monitoring. 6.1 The community pharmacy provider must collect the full gold standard data set in a timely, consistent and complete manner in the required format. Data should be returned to the Specialist Stop Smoking Service within 2 working days of client contact at the following intervention stages: • Initial assessment • 4 week post quit date - follow up at four weeks must take place within the DH stated ‘window’ period of 25 to 42 days post quit date. • 12 week post quit date (or end of treatment) - follow up at twelve weeks must take place between day 77 and before 98 days post quit date • aspire to achieve a minimum of 35, 4 week quitters annually with a minimum quit rate of 35%. • in line with the tariff payment 85% of 4 & 12 week quitters should be carbon monoxide validated. Incomplete data sets will be returned to the provider for completion and return to the SSS with 48 hrs. Monitoring Guidance may be subject to change – if so Service Providers will be informed in writing of changes by the SSSS.
6.2 The pharmacy contractor will ensure that pharmacists and staff involved in the service maintain appropriate records to ensure effective ongoing service delivery and audit. Records will be confidential and must be stored securely and for a length of time in line with NHS record retention policies. Local documentation will be provided for the recording of relevant service information for the purposes of audit and the claiming of payment.
6.3 The pharmacy will inform the client’s GP within 2 working days of dispensing NRT product using the documentation provided (see Appendix 5). GP practices will enter received results onto practice systems.
6.4 Monitoring information over and above that obtained during the delivery of the Stop Smoking Service will include: • information provided by the pharmacy with the self-assessment document prior to signing up for the SLA. • client tracking including as appropriate o pre screening information. o numbers and times of appointments offered and taken up o DNA rates for appointments • exception reporting for unavailability of services • evidence required for audit and monitoring visits
6.5 The SSSS may also facilitate contributions from pharmacy staff and clients towards evaluation and quality improvement of the pharmacy stop smoking services.
